Short Interest in Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) Expands By 165.4%

Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) was the target of a large increase in short interest during the month of December. As of December 15th, there was short interest totaling 35,213 shares, an increase of 165.4% from the November 30th total of 13,267 shares. Currently, 5.4% of the shares of the stock are short sold. Based on an average trading volume of 38,130 shares, the days-to-cover ratio is presently 0.9 days. Based on an average trading volume of 38,130 shares, the days-to-cover ratio is presently 0.9 days. Currently, 5.4% of the shares of the stock are short sold.

Virtus LifeSci Biotech Clinical Trials ETF Price Performance

BBC stock opened at $39.56 on Friday. The firm has a fifty day moving average price of $35.18 and a 200 day moving average price of $27.37. Virtus LifeSci Biotech Clinical Trials ETF has a fifty-two week low of $13.42 and a fifty-two week high of $40.82.

Virtus LifeSci Biotech Clinical Trials ETF Company Profile

The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.